4
Changes in Ownership
Bicara Therapeutics Inc. Filed Acc 0002034665-25-000011
President and COO sold 12,500 shares at $18.68 ($233,548)
- President and COO acquired 8,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cohlhepp Ryan President and COO | 2025-12-15 | Option exercise 10b5-1 | +8,000 | $3.79 | $30,318 | 201,641 | D: show line 1 in the form |
| Cohlhepp Ryan President and COO | 2025-12-15 | Sale 10b5-1 | −8,000 | $18.68 | $149,470 | 193,641 | D: show line 2 in the form |
| Cohlhepp Ryan President and COO | 2025-12-15 | Sale 10b5-1 | −4,500 | $18.68 | $84,077 | 189,141 | D: show line 3 in the form |
| Open-market sales · 12,500 sh · avg $18.68 · $233,548 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Cohlhepp Ryan President and COO | 2025-12-15 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −8,000 | 141,334 | D: show line 4 in the form |
Loading xslF345X05/wk-form4_1765921919.xml…